Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica K Holien

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
RSC Medicinal Chemistry|November 15, 2021
Analysis of physicochemical properties of protein-protein interaction modulators suggests stronger alignment with the "rule of five"Jia Truong, Ashwin George, Jessica K Holien
Expert Opinion on Investigational Drugs|January 16, 2026
KIF18A inhibition and its rising role in cancer therapy trials: from bench to bedsideJia Q Truong, Tal Galper, Jessica K Holien
Antimicrobial Agents and Chemotherapy|August 5, 2009
In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza virusesAeron C Hurt, Jessica K Holien, Ian G Barr
Drugs|December 1, 2009
Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza virusesAeron C Hurt, Jessica K Holien, Michael W Parker, et al.
Journal of Virology|July 31, 2009
Zanamivir-resistant influenza viruses with a novel neuraminidase mutationAeron C Hurt, Jessica K Holien, Michael Parker, et al.
Cell Cycle (Georgetown, Tex.)|May 10, 2013
Molecular and structural insight into lysine selection on substrate and ubiquitin lysine 48 by the ubiquitin-conjugating enzyme Cdc34Randy Suryadinata, Jessica K Holien, George Yang, et al.
Nature Reviews. Cancer|March 14, 2014
Oncogenic protein interfaces: small molecules, big challengesTracy L Nero, Craig J Morton, Jessica K Holien, et al.
Current Oncology Reports|October 1, 2022
Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncologyYali Deng, Doan T M Ngo, Jessica K Holien, et al.
Bioinformatics (Oxford, England)|December 9, 2022
DockNet: high-throughput protein-protein interface contact predictionNathan P Williams, Carlos H M Rodrigues, Jia Truong, et al.
Biotechnology and Bioengineering|May 20, 2026
IMACulate(DE3), an E. coli Strain for High Purity His-Tagged Protein PurificationsJia Q Truong, Dingyi Yu, Nan Hao, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
RSC Medicinal Chemistry|November 15, 2021
Analysis of physicochemical properties of protein-protein interaction modulators suggests stronger alignment with the "rule of five"Jia Truong, Ashwin George, Jessica K Holien
Expert Opinion on Investigational Drugs|January 16, 2026
KIF18A inhibition and its rising role in cancer therapy trials: from bench to bedsideJia Q Truong, Tal Galper, Jessica K Holien
Antimicrobial Agents and Chemotherapy|August 5, 2009
In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza virusesAeron C Hurt, Jessica K Holien, Ian G Barr
Drugs|December 1, 2009
Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza virusesAeron C Hurt, Jessica K Holien, Michael W Parker, et al.
Journal of Virology|July 31, 2009
Zanamivir-resistant influenza viruses with a novel neuraminidase mutationAeron C Hurt, Jessica K Holien, Michael Parker, et al.
Cell Cycle (Georgetown, Tex.)|May 10, 2013
Molecular and structural insight into lysine selection on substrate and ubiquitin lysine 48 by the ubiquitin-conjugating enzyme Cdc34Randy Suryadinata, Jessica K Holien, George Yang, et al.
Nature Reviews. Cancer|March 14, 2014
Oncogenic protein interfaces: small molecules, big challengesTracy L Nero, Craig J Morton, Jessica K Holien, et al.
Current Oncology Reports|October 1, 2022
Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncologyYali Deng, Doan T M Ngo, Jessica K Holien, et al.
Bioinformatics (Oxford, England)|December 9, 2022
DockNet: high-throughput protein-protein interface contact predictionNathan P Williams, Carlos H M Rodrigues, Jia Truong, et al.
Biotechnology and Bioengineering|May 20, 2026
IMACulate(DE3), an E. coli Strain for High Purity His-Tagged Protein PurificationsJia Q Truong, Dingyi Yu, Nan Hao, et al.
Pageof 7